COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Dr. Sandip Patel focuses on early phase clinical trials of cancer immunotherapy across tumor types, with a focus on clinical and translational research. He collaborates with numerous labs at UCSD with a focus on immunotherapy biomarker development.​ 

He has done a clinical trial on Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Show additional content areas below